A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 254
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : WN
Long Form : West Nile
No. Year Title Co-occurring Abbreviation
2021 Flavivirus NS1 and Its Potential in Vaccine Development. JE, NS1, TBE, YF
2021 Serological evidence of West Nile viral infection in archived swine serum samples from Peninsular Malaysia. WNV
2020 A Molecular Screening of Mosquitoes (Diptera: Culicidae) for Flaviviruses in a Focus of West Nile Virus Infection in Northern Iran. ---
2020 CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic Infection. ---
2020 Serological Evidence of West Nile Virus Infection in White-Tailed Deer in Central Texas. ELISA, IgG, SLEV, WNV, WTD
2020 Serological Evidence of Yersiniosis, Tick-Borne Encephalitis, West Nile, Hepatitis E, Crimean-Congo Hemorrhagic Fever, Lyme Borreliosis, and Brucellosis in Febrile Patients Presenting at Diverse Hospitals in Kenya. CCHF, HEV, LD, OR, TBE
2020 Vaccines Against Dengue and West Nile Viruses in India: The Need of the Hour. DEN, JE, NAb, NPs
2018 Multiple insecticide resistance in Culex quinquefasciatus populations from Guadeloupe (French West Indies) and associated mechanisms. ---
2017 Application of replication-defective West Nile virus vector to non-flavivirus vaccine targets. RSV, RV, SIV
10  2017 Knockdown resistance (kdr) of the voltage-gated sodium channel gene of Aedes aegypti population in Denpasar, Bali, Indonesia. DF, kdr, VGSC
11  2017 Surveillance of Arthropod-Borne Viruses and Their Vectors in the Mediterranean and Black Sea Regions Within the MediLabSecure Network. RVF
12  2016 Development of a human live attenuated West Nile infectious DNA vaccine: Identification of a minimal mutation set conferring the attenuation level acceptable for a human vaccine. iDNA
13  2016 Ocular Lesions in Red-Tailed Hawks ( Buteo jamaicensis) With Naturally Acquired West Nile Disease. WNV
14  2015 Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design. ---
15  2015 Profiling of viral proteins expressed from the genomic RNA of Japanese encephalitis virus using a panel of 15 region-specific polyclonal rabbit antisera: implications for viral gene expression. DEN, JEV, YF
16  2014 A glass microchip device for conducting serological survey of West Nile viral antibodies. ELISA
17  2014 An outbreak of West Nile Virus infection in the region of Monastir, Tunisia, 2003. CSF, nRT-PCR, RT-PCR, WNV
18  2013 Increased pathogenicity of West Nile virus (WNV) by glycosylation of envelope protein and seroprevalence of WNV in wild birds in Far Eastern Russia. FRNT, WNV
19  2013 Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus. AEs, YF
20  2013 Protein-protein interactions among West Nile non-structural proteins and transmembrane complex formation in mammalian cells. BiFC, ER, FRET, NSPs, PPI, TP
21  2012 Emerging viral diseases in dromedary camels in the Southern Morocco. AHS, BT, CP, EHD
22  2012 Flaviviruses and their antigenic structure. DEN, JE, TBE, YF
23  2011 MAPREC assay for quantitation of mutants in a recombinant flavivirus vaccine strain using near-infrared fluorescent dyes. EtBr, MAPREC, NIR, WHO
24  2011 Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virus. ---
25  2011 Seroprevalence of West Nile virus in wild birds in far eastern Russia using a focus reduction neutralization test. JE
26  2011 Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis. i.p, SLE, WNV
27  2010 Epidemiology of west nile in europe and in the mediterranean basin. ---
28  2010 Flavitrack analysis of the structure and function of West Nile non-structural proteins. FV, PCP
29  2010 Glycosylation of the West Nile Virus envelope protein increases in vivo and in vitro viral multiplication in birds. NY
30  2010 Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine. CDC, JEV, NS1, WNV
31  2010 TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. ---
32  2009 Development of real time PCR for detection and quantitation of Dengue Viruses. CHK, DENV, JE, MGB
33  2009 Is Culex modestus (Diptera: Culicidae), vector of West Nile virus, spreading in the Dombes area, France? ---
34  2009 Severe winter freezes enhance St. Louis encephalitis virus amplification and epidemic transmission in peninsular Florida. SLE
35  2009 The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses. JE, MVE
36  2008 Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations. Env, WT
37  2008 Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters. NS1
38  2008 Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine. ---
39  2007 Application of modified shell vial culture procedure for arbovirus detection. DEN, GC, ILH, MAY, MSVC, ORO, SCC, SLE, VEE, YF
40  2007 First international diagnostic accuracy study for the serological detection of West Nile virus infection. EIA, EQA, IFA, NT
41  2007 Flavitrack: an annotated database of flavivirus sequences. DF, TBE, YF
42  2007 Infection by certain arboviruses among workers potentially at risk of infection. ELISA, RVF, SFN, SFS, SIN, STPs
43  2007 West Nile viremic blood donors and risk factors for subsequent West Nile fever. NATs, WNF, WNV
44  2007 West Nile virus: recent trends in diagnosis and vaccine development. WNV
45  2006 A live, attenuated recombinant West Nile virus vaccine. PFU, YF
46  2006 Diagnostic performance of the equine IgM capture ELISA for serodiagnosis of West Nile virus infection. CI, ELISA, ROC
47  2006 Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice. ---
48  2006 Host-seeking strategies of mosquito disease vectors. SLE
49  2006 Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults. CHIK, DEN-2, ONN, PRNT, SIN, TAH, YF
50  2006 The kinetics of proinflammatory cytokines in murine peritoneal macrophages infected with envelope protein-glycosylated or non-glycosylated West Nile virus. IFN, IL, TNF
51  2006 Triaryl pyrazoline compound inhibits flavivirus RNA replication. ---
52  2005 A recombinant envelope protein vaccine against West Nile virus. ---
53  2005 Analysis of self-association of West Nile virus capsid protein and the crucial role played by Trp 69 in homodimerization. ---
54  2005 Drought-induced amplification and epidemic transmission of West Nile virus in southern Florida. WNV
55  2005 Duplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies. IgM, MIA, PRNT, SLE
56  2005 Duration of infectivity and RNA of Venezuelan equine encephalitis, West Nile, and yellow fever viruses dried on filter paper and maintained at room temperature. VEE, YF
57  2005 Immunoglobulin M-capture enzyme-linked immunosorbent assay testing of cerebrospinal fluid and serum from horses exposed to west nile virus by vaccination or natural infection. AO, AQ, BBB, CSF, IgM, LS, WNE
58  2005 Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. PMOs
59  2005 Mosquito vectors of the 1998-1999 outbreak of Rift Valley Fever and other arboviruses (Bagaza, Sanar, Wesselsbron and West Nile) in Mauritania and Senegal. BAG, RVF, WSL
60  2005 Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys. i.c, JE
61  2005 Stereophysicochemical variability plots highlight conserved antigenic areas in Flaviviruses. PCPs, SVPs
62  2004 An occipital lobe epileptogenic focus in a patient with West Nile encephalitis. ---
63  2004 Blinded laboratory comparison of the in situ enzyme immunoassay, the VecTest wicking assay, and a reverse transcription-polymerase chain reaction assay to detect mosquitoes infected with West Nile and St. Louis encephalitis viruses. EIA, RT-PCR, SLE
64  2004 ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. JE, YF
65  2004 Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool. prM-E, SLE, YF
66  2004 Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. CSF, IgG
67  2004 Different chemokine expression in lethal and non-lethal murine West Nile virus infection. NY, NY
68  2004 Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines. DEN, JE, PIV, TBE, YF
69  2004 Immunity to West Nile virus. ---
70  2004 Prevalence of antibodies against Saint Louis encephalitis and Jamestown Canyon viruses in California horses. JC, SLE
71  2004 Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of West Nile virus. RT-LAMP
72  2004 Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication. nt
73  2004 The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. SLE
74  2004 Vertical transmission of West Nile Virus by three California Culex (Diptera: Culicidae) species. MFIR
75  2004 Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. NY
76  2004 West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. ---
77  2004 West Nile: worldwide current situation in animals and humans. ---
78  2003 A serological survey of arboviral diseases among the human population of the Andaman and Nicobar Islands, India. CHIK, HI, JE, KFD
79  2003 Detection of anti-West Nile virus immunoglobulin M in chicken serum by an enzyme-linked immunosorbent assay. ELISA, IgM, SLE
80  2003 Discrimination of West Nile virus and Japanese encephalitis virus strains using RT-PCR RFLP analysis. JE, RFLP
81  2003 DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. KUN
82  2003 Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes. prM, vet, YF
83  2003 IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. ---
84  2003 Initiating arbovirus surveillance in Arkansas, 2001. ---
85  2003 Nested multiplex RT-PCR for detection and differentiation of West Nile virus and eastern equine encephalomyelitis virus in brain tissues. EEE, RT-PCR
86  2003 Phylogenetic relationships of West Nile viruses isolated from birds and horses in Israel from 1997 to 2001. ---
87  2003 Poor replication of West Nile virus (New York 1999 strain) in three reptilian and one amphibian species. ---
88  2003 Prevalence of West Nile virus infection in India. JE, NIV
89  2003 Serologic survey of domestic animals for zoonotic arbovirus infections in the Lacandon Forest region of Chiapas, Mexico. BSQ, EEE, ILH, ROC, SLE, VEE, WEE
90  2003 The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. HMGB1, LDH, p.i
91  2003 The membrane proteins of flaviviruses form ion-permeable pores in the target membrane after fusion: identification of the pores and analysis of their possible role in virus infection. ---
92  2003 Transstadial transfer of West Nile virus by three species of ixodid ticks (Acari: Ixodidae). PCR
93  2003 Virologic and serologic investigations of West Nile virus circulation in Belarus. ---
94  2003 West Nile virus infection rates in Culex nigripalpus (Diptera: Culicidae) do not reflect transmission rates in Florida. ---
95  2003 Wicking assays for the rapid detection of West Nile and St. Louis encephalitis viral antigens in mosquitoes (Diptera: Culicidae). SLE, VecTest
96  2002 A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. 2'-5'-OAS
97  2002 Antibody prophylaxis and therapy for flavivirus encephalitis infections. HAMA, mAbs
98  2002 Antigen distribution pattern of West Nile virus in Culex tritaeniorhynchus, Culex vishnui and Culex pseudovishnui mosquitoes. ---
99  2002 Characterization of imidazo[4,5-d]pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase: evidence for activity on the level of substrate and/or enzyme. NTPase
100  2002 Comparison of IgM capture ELISA with a commercial rapid immunochromatographic card test & IgM microwell ELISA for the detection of antibodies to dengue viruses. DF, EM, JE